Cargando…
The role of miR-139-5p in radioiodine-resistant thyroid cancer
PURPOSE: Radioiodine I-131 (RAI) is the therapy of choice for differentiated thyroid cancer (DTC). Between 5% and 15% of DTC patients become RAI refractory, due to the loss of expression/function of iodide metabolism components, especially the Na/I symporter (NIS). We searched for a miRNA profile as...
Autores principales: | Pecce, V., Sponziello, M., Verrienti, A., Grani, G., Abballe, L., Bini, S., Annunziata, S., Perotti, G., Salvatori, M., Zagaria, L., Maggisano, V., Russo, D., Filetti, S., Durante, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514163/ https://www.ncbi.nlm.nih.gov/pubmed/36933170 http://dx.doi.org/10.1007/s40618-023-02059-7 |
Ejemplares similares
-
Establishment and maintenance of thyroid organoids from human cancer cells
por: Pecce, Valeria, et al.
Publicado: (2022) -
Loss of Function SETD2 Mutations in Poorly Differentiated Metastases from Two Hürthle Cell Carcinomas of the Thyroid
por: Pecce, Valeria, et al.
Publicado: (2020) -
Precision oncology for RET-related tumors
por: Verrienti, Antonella, et al.
Publicado: (2022) -
Identification of Thyroid-Associated Serum microRNA Profiles and Their Potential Use in Thyroid Cancer Follow-Up
por: Rosignolo, Francesca, et al.
Publicado: (2017) -
The legacy of the COVID-19 pandemics for thyroid cancer patients: towards the application of clinical practice recommendations
por: Grani, Giorgio, et al.
Publicado: (2022)